Guidelines

• Commissioning and managing screening programmes in the NHS in England (02 March 2016)
• Referral guidelines for suspected cancer in adults and children. (13 January 2016)
• Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care (partial update of CG14) (02 December 2015)
• Epoetin alfa, epoetin beta and darbepoetin alfa for cancer treatment-induced anaemia (25 June 2015)
• New Summary: Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. [American Society of Clinical Oncology] (11 June 2015)
• New Summary: Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer. [National Institute for Health and Care Excellence (NICE)] (19 February 2015)
• New Summary: Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat. [National Institute for Health and Care Excellence (NICE)] (19 February 2015)
• Updated Summary: ACR Appropriateness Criteria® stage I breast cancer: initial workup and surveillance for local recurrence and distant metastases in asymptomatic women. [American College of Radiology] (25 November 2014)
• Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions (20 October 2014)
• Updated Summary: ACR Appropriateness Criteria® palpable breast masses. [American College of Radiology] (20 October 2014)
• Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy (20 October 2014)
• Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer. (20 October 2014)
• Palpable breast masses. (20 October 2014)
• Breast microcalcifications. (20 October 2014)
• Nonpalpable breast masses. (20 October 2014)
• Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer (20 October 2014)
• Updated Summary: ACR Appropriateness Criteria® nonpalpable mammographic findings (excluding calcifications). [American College of Radiology] (20 October 2014)
• Management of breast cancer in women. A national clinical guideline. (20 October 2014)
• Consolidated guidance on standards for the NHS breast screening programme (20 October 2014)
• Work-up of nonpalpable breast masses. (20 October 2014)